BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $18,344,000 | -14.0% | 154,706 | 0.0% | 0.26% | -10.2% |
| Q4 2021 | $21,321,000 | -0.8% | 154,706 | 0.0% | 0.29% | +2.1% |
| Q3 2021 | $21,491,000 | +43.1% | 154,706 | 0.0% | 0.29% | +30.9% |
| Q2 2021 | $15,018,000 | +42.0% | 154,706 | 0.0% | 0.22% | +50.7% |
| Q1 2021 | $10,574,000 | -20.3% | 154,706 | 0.0% | 0.15% | -23.2% |
| Q4 2020 | $13,261,000 | -48.1% | 154,706 | -60.6% | 0.19% | -58.7% |
| Q3 2020 | $25,546,000 | -34.9% | 392,956 | -26.8% | 0.46% | -36.6% |
| Q2 2020 | $39,225,000 | +4.5% | 536,530 | -26.4% | 0.72% | -18.3% |
| Q1 2019 | $37,531,000 | +10.1% | 729,178 | -20.9% | 0.89% | +9.5% |
| Q4 2018 | $34,078,000 | +30.8% | 921,536 | +32.8% | 0.81% | +37.3% |
| Q3 2018 | $26,063,000 | +70.5% | 694,104 | +79.5% | 0.59% | +65.3% |
| Q2 2018 | $15,283,000 | +47.8% | 386,724 | -3.6% | 0.36% | +57.3% |
| Q1 2018 | $10,339,000 | – | 401,322 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |